The Fall Classic Run is held in loving memory of those who are suffering or who have suffered from Alzheimer’s Disease or Dementia. The Run benefits the Razor Sharp Minds Foundation, which proudly supports Alzheimer’s and Dementia research as well as other endeavors related to finding a cure for and educating the public about this debilitating disease.
The Razor Sharp Minds Foundation
Board of Directors
President/Treasurer - Aaron Nodolf
Vice President - Trae Hoepner
Director of Volunteer Services - Kim Nodolf
Secretary - Matt Thull
About the Foundation
The RSM Foundation is in the process of becoming a non-profit entity with the help of Sarah Fowles, an excellent and dedicated attorney at Michael Best & Friedrich. Please know that any donations made to the RSM Foundation after June 11, 2009, are eligible as tax deductions under the IRS Tax Code.
In addition to supporting critical research dedicated to finding a cure for Alzheimer's and dementia, the RSM Foundation supports clinical practice efforts that are dedicated to finding a cure for Alzheimer’s Disease/dementia. The Razor Sharp Minds Foundation also is committed to supporting the development of improved therapies for those living with Alzheimer’s Disease/dementia, and informing the public about Alzheimer’s Disease/dementia, advances in research, and the benefits a healthy lifestyle has on the mind.
More information will be provided as we formalize our foundation. Please contact us if you have any questions.
The Alzheimer's Disease Research Center
The Alzheimer's Disease Research Center at the Mayo Clinic in Rochester, Minnesota assesses persons with memory complaints and persons of the same age and gender who have normal cognitive abilities, and works to translate research advances into improved diagnosis and care for Alzheimer's Disease and related dementia patients while also focusing on the program's long-term goal of finding a way to cure and possibly prevent Alzheimer’s Disease.
The ADRC conducts drug trials, risk factor analyses, patient management, prognosis research, and detailed neuropathologic examinations on patients with mild cognitive impairment and dementia such that a definite diagnosis of the cause can be determined.
ADRC research and clinical studies allow detection of mild abnormal cognitive aging, and identifies individuals with no cognitive symptoms or very mild cognitive decline so that intervention can be given as early as possible.
The ADRC actively researches Alzheimer's disease as well as the other types of dementia such as dementia with Lewy bodies, frontotemporal dementia, primary progressive aphasia, semantic dementia, corticobasal degeneration, posterior cortical atrophy, and vascular dementia.
The ADRC offers:
~ Diagnosis and medical management.
~ Information about the disease, as well as appropriate services and resources for patients and families.Opportunities for volunteers to participate in drug trials, clinical research projects, and special studies.
~ Opportunities for volunteers to participate in drug trials, clinical research projects, and special studies.